Pharmaceutical Industry News
Big pharma scores in US healthcare reform
Friday, 26, March 2010
President Obama has signed the biggest US healthcare reform since the 1960s, and although it is largely seen as a victory for the pharmaceutical industry, some analysts are characterising it as a 'double-edged sword'.The legislation, signed into law amid much fanfare on 23 March, is 'not perfect' but represents a step in the right direction by helping to ensure that all Americans have access to high-quality and affordable healthcare, according to the Pharmaceutical Research and Manufacturers of America (PhRMA) - a lobby group representing the country's leading pharmaceutical companies.
The reform bill did not have an easy ride into the law books, and has been sent back to the House of Representatives under a process known as budget reconciliation after two points were found to violate Senate procedure.The new law is expected to expand health insurance coverage to more than 30 million uninsured Americans, but estimates indicate that more than 20 million will still go without.